標記臨牀研究 XOMA 深 滬
等待開盤 03-26 09:30:00 美东时间
30.20
+0.980
+3.35%
華盛通- 最 高30.95
- 今 開29.36
- 成交量 10.08万股
- 最 低 29.36
- 昨 收 29.22
- 總市值 3.59亿
- 52周最高 39.92
- 市盈率 靜 20.74
- 換手率 0.85%
- 52周最低 18.352
- 委 比 79.35%
- 總股本 1188.85万
- 歷史最高 191.40
- 量 比 0.89
- 振 幅 5.44%
- 歷史最低 3.96
- 每 手 1
- 風險率 4.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
XOMA Royalty Corporation (XOMA) Gets a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on XOMA Royalt...
03-20 18:36
HC Wainwright & Co. Reiterates Buy on XOMA Royalty, Maintains $97 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates XOMA Royalty (NASDAQ:XOMA) with a Buy and maintains $97 price target.
03-20 18:30
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Corporation announced cash dividends for its Series A and Series B Cumulative Preferred Stock. Series A holders will receive $0.53906 per share, while Series B depositary shares will receive $0.52344 per share. Payments are scheduled for April 15, 2026, to holders of record as of April 2, 2026. XOMA Royalty specializes in acquiring future economic rights from biotech therapies, providing non-dilutive funding to sellers and potential ...
03-18 20:30
Earnings Scheduled For March 18, 2026
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
XOMA Q4 EPS $0.26 Beats $(0.15) Estimate, Sales $13.757M Beat $11.049M Estimate
XOMA (NASDAQ:XOMA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $(0.15) by 267.74 percent. This is a 157.78 percent increase over losses of $(0.45) per share from the same
03-18 18:34
XOMA Royalty schedules webcast to discuss fourth-quarter and full-year results
XOMA Royalty schedules webcast to discuss fourth-quarter and full-year results XOMA Royalty will report fourth-quarter and full-year 2025 financial results on March 18, 2026. The company will host a webcast on March 18, 2026 at 8:00 am Eastern Time. The webcast will be available at XOMA Royalty News
03-12 18:30
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
XOMA Royalty Corporation will announce its fourth-quarter and full-year 2025 financial results on March 18, 2026, followed by a webcast at 8:00 am Eastern Time to discuss the results and provide a business update. The webcast will be accessible on the company's "News & Events" page, with a replay available for 30 days. XOMA Royalty is a biotech royalty aggregator that acquires potential future economics associated with therapeutic candidates, pro...
03-12 10:30
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
XOMA Royalty to Present at Investor Conferences in March
XOMA Royalty Corporation announced that its Executive Team will participate in two investor conferences in March: the T.D. Cowen 46th Annual Health Care Conference in Boston on March 2, 2026, and the Leerink 2026 Global Healthcare Conference in Miami Beach on March 11, 2026. Both events will feature fireside chats, and management will also engage in one-on-one investor meetings. Presentations will be available on the company's website for 90 days...
02-18 21:30
